Efficacy of risankizumab rescue therapy in patients with moderately to severely active Crohn's Disease and inadequate response to risankizumab maintenance therapy

被引：0
|
作者：
Baert, F. J. [1 ]
Atreya, R. [2 ]
Kakuta, Y. [3 ]
Long, M. [4 ]
Roblin, X. [5 ]
Neimark, E. [6 ]
Song, A. [6 ]
Wallace, K. [6 ]
Kingys, K. [6 ]
Mallick, M. [6 ]
Liao, X. [6 ]
Lim, A. [7 ]
机构：
[1] AZ Delta, Dept Gastroenterol, Roeselare Menen, Belgium
[2] Friedrich Alexander Univ Erlangen Nurnberg, Dept Med, Univ Hosp Erlangen, Erlangen, Germany
[3] Tohoku Univ, Div Gastroenterol, Grad Sch Med, Seiryo Aoba Sendai, Miyagi, Japan
[4] Univ N Carolina, Div Gastroenterol & Hepatol, Multidisciplinary Ctr Inflammatory Bowel Dis, Chapel Hill, NC 27515 USA
[5] Univ Hosp St Etienne, Dept Gastroenterol, St Etienne, France
[6] AbbVie Inc, Dept Gastroenterol, N Chicago, IL USA
[7] John Flynn Private Hosp, Dept Gastroenterol, Tugun, Qld, Australia
来源：
JOURNAL OF CROHNS & COLITIS | 2022年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
DOP85
引用
收藏
页码：I128 / I128
页数：1
相关论文
共 50 条
  • [1] EFFICACY OF RISANKIZUMAB RESCUE THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE AND INADEQUATE RESPONSE TO RISANKIZUMAB MAINTENANCE THERAPY
    Baert, Filip J.
    Atreya, Raja
    Kakuta, Yoichi
    Long, Millie D.
    Roblin, Xavier
    Neimark, Ezequiel
    Song, Alexandra P.
    Wallace, Kori
    Kligys, Kristina
    Mallick, Madhuja
    Liao, Xiaomei
    Lim, Allen
    [J]. GASTROENTEROLOGY, 2022, 162 (07) : S967 - S967
  • [2] Characterisation of endoscopic improvements with risankizumab treatment in patients with moderately to severely active Crohn's disease
    Reinisch, W.
    Colombel, J. F.
    Ma, C.
    Long, M.
    Irving, P. M.
    O'Brien, D.
    Kligys, K.
    Song, A.
    Zhang, Y.
    D'Haens, G.
    [J]. JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1378 - I1379
  • [3] Crohn's Disease: Risankizumab as Induction- and Maintenance Therapy
    Franke, Katharina
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2022, 147 (17) : 1085 - 1085
  • [4] EFFICACY OF RISANKIZUMAB BY BASELINE CLINICAL, BIOCHEMICAL, AND ENDOSCOPIC DISEASE SEVERITY IN MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE
    Panaccione, Remo
    D'Haens, Geert
    Seenan, John Paul
    Caprioli, Flavio
    Siegel, Corey A.
    Nakamura, Masanao
    Wei, Shu Chen
    Kligys, Kristina
    Zhang, Yafei
    Zambrano, Javier A.
    Song, Alexandra P.
    Ferrante, Marc
    [J]. GASTROENTEROLOGY, 2023, 164 (06) : S1097 - S1098
  • [5] Efficacy of risankizumab by baseline clinical, biochemical, and endoscopic disease severity in moderately to severely active Crohn's disease
    Panaccione, R.
    D'Haens, G.
    Seenan, J. P.
    Caprioli, F.
    Siegel, C.
    Nakamura, M.
    Wei, S. C.
    Kligys, K.
    Zhang, Y.
    Zambrano, J.
    Song, A. P.
    Ferrante, M.
    [J]. JOURNAL OF CROHNS & COLITIS, 2023, 17 : 560 - 560
  • [6] Risankizumab Maintenance Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Efficacy and Safety in the Randomised Phase 3 COMMAND Study
    Louis, E.
    Panaccione, R.
    Parkes, G.
    Peyrin-Biroulet, L.
    Ferrante, M.
    Hisamatsu, T.
    Siegmund, B.
    Kalabic, J.
    Levine, P.
    Neimark, E.
    Wallace, K.
    Chen, S.
    Cheng, L.
    Duan, W. R.
    Armuzzi, A.
    Biederman, L.
    Loftus, E.
    Melmed, G.
    Schreiber, S.
    [J]. JOURNAL OF CROHNS & COLITIS, 2024, 18 : I10 - I12
  • [7] Crohn's Disease: Risankizumab as Induction- and Maintenance Therapy Comment
    Atreya, Raja
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2022, 147 (17) : 1086 - 1087
  • [8] Risankizumab to treat moderately to severely active Crohn's disease in adults: an evaluation of trials and data
    Johnson, Amanda M.
    Loftus Jr, Edward V.
    [J]. EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2023, 17 (12) : 1169 - 1183
  • [9] Achievement of steroid-free remission in patients with moderately to severely active Crohn's Disease during treatment with risankizumab
    Schreiber, S. W.
    Cross, R.
    Panaccione, R.
    D'Haens, G.
    Bossuyt, P.
    Colombel, J. F.
    Louis, E.
    Dubinsky, M.
    Kligys, K.
    Neimark, E.
    Song, A.
    Zambrano, J.
    Cheng, E.
    Ferrante, M.
    [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 : I125 - I126
  • [10] ACHIEVEMENT OF STEROID-FREE REMISSION IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE DURING TREATMENT WITH RISANKIZUMAB
    Schreiber, Stefan
    Cross, Raymond K.
    Panaccione, Remo
    D'Haens, Geert
    Bossuyt, Peter
    Colombel, Jean Frederic
    Louis, Edouard
    Dubinsky, Marla
    Kligys, Kristina
    Neimark, Ezequiel
    Song, Alexandra P.
    Zambrano, Javier A.
    Cheng, Erica
    Ferrante, Marc
    [J]. GASTROENTEROLOGY, 2022, 162 (07) : S966 - S966
12345